A look at evidence and value in a time of social and policy change.
Dave Thompson
Advertisement
Articles by Dave Thompson
Advertisement
Latest Updated Articles
- Insights from ISPOR 2017
Published: June 9th 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
